Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2‑positive breast cancer
International Journal of Molecular Medicine · 2026
DOI: 10.3892/ijmm.2026.5751 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Medicine, 2026. Verfasst von Eunsun Jung und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 152‑703, Republic of Kor…. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Drug Resistance, Neoplasm, Breast Neoplasms, Trastuzumab. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
safety profile. These findings demonstrated that ebastine effectively disrupts key pathways involved in CSC‑like traits and HER2 activity, even under trastuzumab‑resistant conditions. Its multifaceted inhibitory effects support the repositioning of ebastine as a promising therapeutic strategy for treating refractory HER2‑positive breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 152‑703, Republic of Korea.
Zitieren
APA
Jung, E., Kim, J. Y., Ko, D., Seo, J., Lee, S. Y., Lee, D., Kim, S., Park, M., Kim, S., Park, S., Lee, K., Kang, Y. K., Nam, K. D., Kim, Y. J., & Seo, J. H. (2026). Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2‑positive breast cancer. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2026.5751
Vancouver
Jung E, Kim JY, Ko D, Seo J, Lee SY, Lee D, et al. Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2‑positive breast cancer. International Journal of Molecular Medicine. 2026. doi:10.3892/ijmm.2026.5751
BibTeX
@article{Jung2026,
author = {Jung, Eunsun and Kim, Ji Young and Ko, Dongmi and Seo, Juyeon and Lee, Sang Yoon and Lee, Daeun and Kim, Subeen and Park, Minsu and Kim, Seongjae and Park, Soeun and Lee, Kyoungmin and Kang, Yong Koo and Nam, Kee Dal and Kim, Yoon-Jae and Seo, Jae Hong},
title = {Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2‑positive breast cancer},
journal = {International Journal of Molecular Medicine},
year = {2026},
doi = {10.3892/ijmm.2026.5751}
}
EUVIMED